Synergistic Anti-Cancer Effects of Curcumin and Thymoquinone Against Melanoma

Overview

Journal Antioxidants (Basel)

Date 2025 Jan 8

PMID 39765900

Authors

Hana Mohd

Bozena Michniak-Kohn

Affiliations

Soon will be listed here.

Abstract

Combining anti-cancer agents in cancer therapies is becoming increasingly common because of their improved efficacy, reduced toxicity, and decreased risk of resistance development. Melanoma, a highly aggressive form of skin cancer characterized by limited treatment options due to chemoresistance, poses a considerable challenge for effective management. Here, we test the hypothesis that dietary supplements such as thymoquinone (TQ) and curcumin (CU) cooperatively modulate cancer-associated cellular mechanisms to inhibit melanoma progression. Through a series of in vitro experiments utilizing the A375 melanoma cell line, including assessments of cell viability, apoptosis, multicellular tumor spheroid models, reactive oxygen species (ROS) quantification, metabolomics analysis, and RNA sequencing, we established that the combined application of TQ and CU exhibited superior anti-tumor effects compared to their individual use. Our results indicate that the combination treatment significantly inhibited cell viability and induced apoptosis more effectively than either agent alone, with optimal synergy observed at concentrations of 25 µM CU and 10 µM TQ against A375 cells. Additionally, the combination treatment markedly elevated ROS levels, selectively activating the mitochondrial apoptotic pathway via caspase-9. Differential gene expression analysis further revealed a unique synergistic effect of the combination treatment, with enhanced regulation of genes related to oxidative stress and apoptosis. Notably, pathways such as mitochondrial apoptotic signaling and redox homeostasis were more effectively influenced by the combination, with genes such as GPX3, CYP4F11, and HSPB8 cooperatively regulated. Overall, the findings suggest that, in combination, TQ and CU acts synergistically against melanoma; however, further experimental and clinical studies are required to confirm its therapeutic potential.

References

Park J, Kim D, Ha E, Choi S, Choi J, Chun K . Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3. Chem Biol Interact. 2019; 312:108799. DOI: 10.1016/j.cbi.2019.108799. View

Saddiq A, El-Far A, Mohamed Abdullah S, Godugu K, Almaghrabi O, Mousa S . Curcumin, thymoquinone, and 3, 3'-diindolylmethane combinations attenuate lung and liver cancers progression. Front Pharmacol. 2022; 13:936996. PMC: 9277483. DOI: 10.3389/fphar.2022.936996. View

Li P, Zhou L, Zhao T, Liu X, Zhang P, Liu Y . Caspase-9: structure, mechanisms and clinical application. Oncotarget. 2017; 8(14):23996-24008. PMC: 5410359. DOI: 10.18632/oncotarget.15098. View

Cui M, Liu D, Xiong W, Wang Y, Mi J . ERRFI1 induces apoptosis of hepatocellular carcinoma cells in response to tryptophan deficiency. Cell Death Discov. 2021; 7(1):274. PMC: 8490388. DOI: 10.1038/s41420-021-00666-y. View

Yang X, Cen Z, Cheng H, Shi K, Bai J, Xie F . L-3-n-Butylphthalide Protects HSPB8 K141N Mutation-Induced Oxidative Stress by Modulating the Mitochondrial Apoptotic and Nrf2 Pathways. Front Neurosci. 2017; 11:402. PMC: 5506380. DOI: 10.3389/fnins.2017.00402. View

Zhang Y, Li Y, Lv Y, Wang J . Effect of curcumin on the proliferation, apoptosis, migration, and invasion of human melanoma A375 cells. Genet Mol Res. 2015; 14(1):1056-67. DOI: 10.4238/2015.February.6.9. View

Jin H, Wang L, Bernards R . Rational combinations of targeted cancer therapies: background, advances and challenges. Nat Rev Drug Discov. 2022; 22(3):213-234. DOI: 10.1038/s41573-022-00615-z. View

Gorreja F, Rush S, Kasper D, Meng D, Walker W . The developmentally regulated fetal enterocyte gene, , mediates anti-inflammation by the symbiotic bacterial surface factor polysaccharide A on . Am J Physiol Gastrointest Liver Physiol. 2019; 317(4):G398-G407. PMC: 6842988. DOI: 10.1152/ajpgi.00046.2019. View

Kapalczynska M, Kolenda T, Przybyla W, Zajaczkowska M, Teresiak A, Filas V . 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch Med Sci. 2018; 14(4):910-919. PMC: 6040128. DOI: 10.5114/aoms.2016.63743. View

10.

Shain A, Bastian B . From melanocytes to melanomas. Nat Rev Cancer. 2016; 16(6):345-58. DOI: 10.1038/nrc.2016.37. View

11.

Longley D, Johnston P . Molecular mechanisms of drug resistance. J Pathol. 2005; 205(2):275-92. DOI: 10.1002/path.1706. View

12.

Ashour A, Ahmed A, Kumar A, Zoheir K, Aboul-Soud M, Ahmad S . Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression. Mol Cell Biochem. 2016; 416(1-2):141-55. DOI: 10.1007/s11010-016-2703-4. View

13.

Jiang A, Jiang G, Li L, Zheng J . Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells. Mol Biol Rep. 2014; 42(1):267-75. DOI: 10.1007/s11033-014-3769-2. View

14.

Nakamura H, Takada K . Reactive oxygen species in cancer: Current findings and future directions. Cancer Sci. 2021; 112(10):3945-3952. PMC: 8486193. DOI: 10.1111/cas.15068. View

15.

Zhou X, Hao Q, Liao P, Luo S, Zhang M, Hu G . Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator. Elife. 2016; 5. PMC: 4943851. DOI: 10.7554/eLife.15099. View

16.

Pavlovic M, Nikolic S, Gligorijevic N, Dojcinovic B, Arandelovic S, Grguric-Sipka S . New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action. J Biol Inorg Chem. 2019; 24(2):297-310. DOI: 10.1007/s00775-019-01647-4. View

17.

Chu S, Hsieh Y, Yu C, Lai Y, Chen P . Thymoquinone induces cell death in human squamous carcinoma cells via caspase activation-dependent apoptosis and LC3-II activation-dependent autophagy. PLoS One. 2014; 9(7):e101579. PMC: 4085014. DOI: 10.1371/journal.pone.0101579. View

18.

Yi Z, Jiang L, Zhao L, Zhou M, Ni Y, Yang Y . Glutathione peroxidase 3 (GPX3) suppresses the growth of melanoma cells through reactive oxygen species (ROS)-dependent stabilization of hypoxia-inducible factor 1-α and 2-α. J Cell Biochem. 2019; 120(11):19124-19136. DOI: 10.1002/jcb.29240. View

19.

Li Y, Sun F, Li C, Mo H, Zhou Y, Lv D . RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer. Mil Med Res. 2023; 10(1):34. PMC: 10369725. DOI: 10.1186/s40779-023-00470-y. View

20.

Nirgude S, Choudhary B . Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochem Pharmacol. 2020; 184:114365. DOI: 10.1016/j.bcp.2020.114365. View